Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutationsViktor Ljungström, Richard Rosenquist, Stavroula Ntoufa et al.|Blood|2015Cited by 154
An open-label phase I dose-finding study of APR-246 in hematological malignanciesStefan Deneberg, Sören Lehmann, Honar Cherif et al.|Blood Cancer Journal|2016Cited by 85
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case‐matched studyFortunato Morabito, Massimo Offidani, Sara Galimberti et al.|American Journal of Hematology|2013Cited by 26